The Women in Pharma (WIP) Networking Community launched its first education series at the ISPE 2016 Annual Meeting & Expo. Thank you Fran Zipp and Charlotte Enghave Fruergaard for leading this important initiative. One goal for this group was to fund a scholarship through the sale of Women in Pharma lapel pins. Since the inaugural event took place at our conference in Atlanta, Georgia, we dedicated the first Women in Pharma Scholarship to a student at University of Georgia (UGA).
I am very pleased to share that Wided Najahi-Missaoui was granted the ISPE’s first Women in Pharma Scholarship. She is currently a fifth-year doctoral student at UGA, investigating nanoparticulate drug delivery systems such as liposomes to target therapies for prostate and breast cancer. Her overall goal is to integrate the pathophysiology of cancer with the pharmacology of these drug delivery systems to develop more efficient targeted cancer therapies.
Read this iSpeak post to learn more about Wided’s personal and professional journey.
Join myself and Wided Najahi-Missaoui at the ISPE 2017 Annual Meeting & Expo in San Diego, California where we are proud to host two sessions dedicated to the success of Women in Pharma. Key female executives in the pharmaceutical industry will lead these sessions focusing on professional development and technical knowledge.
We are thrilled to share our new interactive website!
This newly redesigned website was crafted to provide our Members and potential Members with an interactive, fluid means to access all that ISPE has to offer—incorporating streamlined navigation, clear design, and a responsive layout.
John Bournas, ISPE CEO and President, said it best, “As ISPE’s global presence continues to thrive, we want our website to reflect that growth. Our team worked diligently to craft a website that would be truly beneficial to all of our visitors worldwide, creating an advanced, informative, and easy to navigate channel to access our full spectrum of resources and benefits.”
Read this iSpeak post for an overview of the six biggest beneficial user benefits.
We hope you enjoy exploring ISPE’s new website, learning more about our full spectrum of resources available to support your professional initiatives and those of the pharmaceutical manufacturing industry.
See you all in San Diego!
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...